News

GeoVax to Participate in BIO International Convention 2025
GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and ...
GeoVax Responds to WHO's Fourth Declaration of Mpox as a Global Public Health Emergency
GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today issued a statement in response to the World Health Organization’s ...
Hosted on MSN6mon
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks
Shares of GeoVax Labs Inc. ($GOVX), SIGA Technologies Inc. ($SIGA), and Emergent Biosolutions Inc. ($EBS) gained in mid-day trading on Friday after the World Health ...
Business Insider1y
Progress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023
Single-Dose Protection Demonstrated Against Multiple SARS-CoV-2 Variants ATLANTA, GA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology ...
The Business Journals2y
Atlanta company GeoVax raises more money for Covid-19 vaccine, cancer treatment trials
The $20 million will be used to accelerate three ongoing clinical trials by the company for Covid-19 vaccines and cancer treatments. In January, GeoVax raised $10 million for the same clinical trials.
MarketWatch9mon
GeoVax’s stock soars 43% to lead rally in companies developing mpox treatments
GeoVax Labs Inc.’s stock soared 43% Monday to lead a fresh rally among companies developing treatments for mpox, after rival Siga Technologies Inc. said a trial of its antiviral failed to meet i ...
Nasdaq3d
GeoVax Announces Upcoming Presentation at the European Hematology Association 2025 Congress Highlighting Positive Immune Response Data for GEO-CM04S1 in CLL Patients
ATLANTA, GA - June 10, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies against infectious ...
Yahoo Finance3d
GeoVax Responds to WHO's Fourth Declaration of Mpox as a Global Public Health Emergency
ATLANTA, GA - June 11, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today issued a ...
Morningstar9mon
GeoVax's stock soars 43% to lead rally in companies developing mpox treatments
Latest stock move comes after rival Siga said a trial of its mpox antiviral failed to meet its main goal GeoVax Labs Inc.'s stock soared 43% Monday to lead a fresh rally among companies developing ...